Reactive episodes in borderline lepromatous leprosy--a case report

Area of Science:

• Dermatology
• Infectious Diseases
• Leprosy Research

Background:

• Leprosy, a chronic infectious disease, requires long-term treatment.
• Dapsone is a primary medication for leprosy management.
• Leprosy reactions can manifest with diverse and severe dermatological symptoms.

Observation:

• A 37-year-old male with borderline lepromatous leprosy presented with widespread silvery scales and facial lesions.
• The patient developed a pustular reaction after one week of dapsone therapy.
• Scarring was noted in some areas of the skin.

Findings:

• The case illustrates a severe cutaneous reaction potentially linked to dapsone treatment in leprosy.
• The development of pustular reactions indicates a complex immune response.
• The patient's condition required careful monitoring and potential treatment adjustment.

Implications:

• This case underscores the importance of monitoring for adverse drug reactions during leprosy treatment.
• Understanding leprosy reactional patterns is crucial for effective patient management.
• Further research may be needed to explore alternative treatment strategies or management protocols for such reactions.